Parent Satisfaction with Sustained Home Visiting Care for Mothers and Children: An Integrative Review

Abstract Aim To synthesise and analyse the existing literature regarding parent satisfaction with sustained home visiting care for mothers and children Background Sustained home visiting programs have been found to support improved health, wellbeing, and developmental outcomes for children and families. However, there is limited knowledge with regards to the level of parent satisfaction with care provided at home, and the factors and elements of care parents perceive to be critical to their satisfaction. It is important for healthcare practitioners to understand what practices and process parents consider to be a priority in securing their ongoing engagement. Design: Integrative review Data sources: PubMed/Medline, CINAHL, Embase, and PsycINFO Methods A multi-step approach was used to search and retrieve peer-reviewed studies from the databases. Study selection, data extraction, data synthesis and critical appraisal were undertaken by two independent researchers. Results A total of 13 studies met the inclusion criteria, including nine quantitative and four qualitative studies. The review found that parents provided with home visiting interventions had higher levels of satisfaction with care than those who received routine or facility-based care. Service dose was a factor associated with parent satisfaction. Other elements of care parents perceived as important to service satisfaction included the strength of the nurse-client relationship, being treated with respect, empowerment, and emotional support. Conclusion While it is critically important that home visiting practitioners provide evidence-based care and interventions, it is equally important that services are delivered in the context of positive and empowering relationships. Further research is recommended to understand the care process and mechanisms that enhance parent satisfaction and positive experiences, providing optimal quality of care.

Download Full-text

An Integrative Review of Parent Satisfaction with Care Provided in the Neonatal Intensive Care Unit

Journal of Obstetric Gynecologic & Neonatal Nursing ◽

10.1111/1552-6909.12003 ◽

2013 ◽

Vol 42 (1) ◽

pp. E1-E2 ◽

Cited By ~ 1

Author(s):

Michelle L. Butt ◽

Jacqueline M. McGrath ◽

Haifa (Abou) Samra ◽

Rebecca Gupta

Keyword(s):

Intensive Care Unit ◽

Intensive Care ◽

Neonatal Intensive Care Unit ◽

Neonatal Intensive Care ◽

Parent Satisfaction ◽

Integrative Review ◽

Satisfaction With Care

Download Full-text

An Integrative Review of Parent Satisfaction with Care Provided in the Neonatal Intensive Care Unit

Journal of Obstetric Gynecologic & Neonatal Nursing ◽

10.1111/1552-6909.12002 ◽

2013 ◽

Vol 42 (1) ◽

pp. 105-120 ◽

Cited By ~ 27

Author(s):

Michelle L. Butt ◽

Jacqueline M. McGrath ◽

Haifa (Abou) Samra ◽

Rebecca Gupta

Keyword(s):

Intensive Care Unit ◽

Intensive Care ◽

Neonatal Intensive Care Unit ◽

Neonatal Intensive Care ◽

Parent Satisfaction ◽

Integrative Review ◽

Satisfaction With Care

Download Full-text

Do Home Visiting Interventions Need to Strengthen Families in Order to Improve Outcomes for Children?

PsycEXTRA Dataset ◽

10.1037/e516652013-229 ◽

2010 ◽

Author(s):

Lynn Kemp

Keyword(s):

Home Visiting ◽

Outcomes For Children

Download Full-text

Epidemiology of hepatitis E virus infection in animals in Africa: a systematic review and meta-analysis

BMC Veterinary Research ◽

10.1186/s12917-021-02749-5 ◽

2021 ◽

Vol 17 (1) ◽

Author(s):

Abdou Fatawou Modiyinji ◽

Jean Joel Bigna ◽

Sebastien Kenmoe ◽

Fredy Brice N. Simo ◽

Marie A. Amougou ◽

...

Keyword(s):

Systematic Review ◽

Hepatitis E Virus ◽

Data Extraction ◽

Meta Analysis ◽

Hepatitis E ◽

Epidemiological Studies ◽

Cross Sectional ◽

Resource Limited ◽

Study Selection ◽

Language Restriction

Abstract Background Hepatitis E virus (HEV) is a major cause of acute hepatitis in humans worldwide and have high burden in the resource-limited countries. Better knowledge of the epidemiology of hepatitis in animals in Africa can help to understand the epidemiology among humans. The objective of this study was to summarize the prevalence of HEV infection and distribution of HEV genotypes among animals in Africa. Methods In this systematic review and meta-analysis, we comprehensively searched PubMed, EMBASE, African Journals Online, and Africa Index Medicus from January 1st, 2000 to March 22th, 2020 without any language restriction. We considered cross-sectional studies of HEV infection in animals in Africa. Study selection, data extraction, and methodological quality of included studies were done independently by two investigators. Prevalence data were pooled using the random-effects meta-analysis. This review was registered in PROSPERO, CRD42018087684. Results Twenty-five studies (13 species and 6983 animals) were included. The prevalence (antibodies or ribonucleic acid [RNA]) of HEV infection in animals varied widely depending on biological markers of HEV infection measured: 23.4% (95% confidence interval; 12.0–37.2) for anti-HEV immunoglobulins G, 13.1% (3.1–28.3) for anti-HEV immunoglobulins M, and 1.8% (0.2–4.3) for RNA; with substantial heterogeneity. In subgroup analysis, the immunoglobulins G seroprevalence was higher among pigs 37.8% (13.9–65.4). The following HEV genotypes were reported in animals: Rat-HEV genotype 1 (rats and horses), HEV-3 (pigs), HEV-7 (dromedaries), and Bat hepeviruses (bats). Conclusions We found a high prevalence of HEV infection in animals in Africa and HEV genotypes close to that of humans. Some animals in Africa could be the reservoir of HEV, highlighting the need of molecular epidemiological studies for investigating zoonotic transmission.

Download Full-text

Lead in Mineral or Multivitamin-Multimineral Products

Annals of Pharmacotherapy ◽

10.1177/10600280211023328 ◽

2021 ◽

pp. 106002802110233

Author(s):

C. Michael White

Keyword(s):

English Language ◽

Data Extraction ◽

The United States ◽

Third Party ◽

Reference Level ◽

Study Selection ◽

Pubmed Search ◽

Zinc Supplements ◽

Average Lead ◽

Year 2000

Objective Assess the current daily interim reference level of lead and the amount contained in current mineral and multivitamin-multimineral (MVM) products. Data Sources PubMed search from 1980 to May 15, 2021, limited to the English language, via the search strategy ((mineral OR multivitamin OR calcium OR iron OR magnesium OR copper OR zinc OR chromium OR selenium) AND (heavy metals OR Pb OR lead)). Study Selection and Data Extraction Narrative review of studies assessing lead content in mineral or MVM products. Data Synthesis Products containing different calcium forms (dolomite, bone meal, natural carbonate) have historically had higher lead levels than others (refined carbonate, lactate, gluconate, acetate, sevelamer), but the gap has closed considerably since the year 2000. Although only limited assessments of magnesium and zinc supplements have been conducted, no alarming average lead amounts were found. MVM products assessed since 2007 had low median or mean lead concentrations. However, large interproduct differences exist, with many products having very little lead and some products having concerning amounts. Relevance to Patient Care and Clinical Practice It is difficult for pharmacists and consumers to know the amount of lead in an actual product unless it is tested in an independent third-party lab. The United States Pharmacopeia and NSF International will provide a seal on the products stating that the products have a low level of lead, but even so, children could receive more lead than the Food and Drug Administration’s Interim Reference Level. Conclusions The threat from lead exposure in mineral and MVM products have diminsihed considerably over time but some products can still have excessive amounts. Without third-party testing, it is difficult for clinicians and consumers to know which outlier products to avoid.

Download Full-text

Prioritising recommendations following analyses of adverse events in healthcare: a systematic review

BMJ Open Quality ◽

10.1136/bmjoq-2019-000843 ◽

2020 ◽

Vol 9 (4) ◽

pp. e000843

Author(s):

Kelly Bos ◽

Maarten J van der Laan ◽

Dave A Dongelmans

Keyword(s):

Systematic Review ◽

Adverse Events ◽

Data Extraction ◽

Data Sources ◽

Cochrane Library ◽

High Quality ◽

Data Synthesis ◽

Study Selection ◽

Personal Opinion ◽

User Friendly

PurposeThe purpose of this systematic review was to identify an appropriate method—a user-friendly and validated method—that prioritises recommendations following analyses of adverse events (AEs) based on objective features.Data sourcesThe electronic databases PubMed/MEDLINE, Embase (Ovid), Cochrane Library, PsycINFO (Ovid) and ERIC (Ovid) were searched.Study selectionStudies were considered eligible when reporting on methods to prioritise recommendations.Data extractionTwo teams of reviewers performed the data extraction which was defined prior to this phase.Results of data synthesisEleven methods were identified that are designed to prioritise recommendations. After completing the data extraction, none of the methods met all the predefined criteria. Nine methods were considered user-friendly. One study validated the developed method. Five methods prioritised recommendations based on objective features, not affected by personal opinion or knowledge and expected to be reproducible by different users.ConclusionThere are several methods available to prioritise recommendations following analyses of AEs. All these methods can be used to discuss and select recommendations for implementation. None of the methods is a user-friendly and validated method that prioritises recommendations based on objective features. Although there are possibilities to further improve their features, the ‘Typology of safety functions’ by de Dianous and Fiévez, and the ‘Hierarchy of hazard controls’ by McCaughan have the most potential to select high-quality recommendations as they have only a few clearly defined categories in a well-arranged ordinal sequence.

Download Full-text

Pharmacological Management of Steroid-Induced Psychosis: A Review of Patient Cases

Journal of Pharmacy Technology ◽

10.1177/8755122520978534 ◽

2020 ◽

pp. 875512252097853

Author(s):

Grace Huynh ◽

Justin P. Reinert

Keyword(s):

Adverse Drug Events ◽

Data Extraction ◽

Management Strategies ◽

Pharmacological Intervention ◽

Symptom Presentation ◽

Pharmacological Management ◽

Diagnostic And Statistical Manual ◽

Study Selection ◽

Cord Injury ◽

Male Patients

Objective: To review the efficacy and safety of medications used in the management of steroid-induced psychosis. Data Sources: A comprehensive literature search was conducted using PubMed, MEDLINE, ProQuest, and Scopus between May and October 2020 using the following search terminology: “steroid-induced psychosis” OR “corticosteroid-induced psychosis.” Study Selection and Data Extraction: Definitive cases, as defined by the Diagnostic and Statistical Manual of Mental Disorders, 5th edition, were included in this review. Geriatric patients >65 years of age, those with a confounding neurological condition such as a traumatic brain or spinal cord injury, or those with active malignancy were excluded. Data Synthesis: A total of 13 patient cases were included in this review, representing 8 male patients and 5 female patients. The mean age at symptom presentation was 42.5 years. Six patients presented with delusions, 5 presented with hallucinations, and 2 presented with both manifestations; 12 patients were managed with an antipsychotic, with haloperidol being the most commonly prescribed, followed by risperidone. One patient was managed with lithium and clonazepam alone. All patients returned to their psychological baseline upon the discontinuation or decreased dose of steroids in combination with Pharmacological intervention, though the time to resolution of symptoms varied significantly. No notable adverse drug events associated with treatments were reported. Conclusions: Steroid-induced psychosis is a serious adverse effect of corticosteroid therapy; however, management strategies that combine a dose reduction or elimination of steroids, in combination with an antipsychotic medication, are effective in resolving this syndrome.

Download Full-text

Recent Advances: Antiinfectives

Annals of Pharmacotherapy ◽

10.1177/106002809502901015 ◽

1995 ◽

Vol 29 (10) ◽

pp. 1035-1040 ◽

Cited By ~ 2

Author(s):

Laurie L Briceland ◽

John D Cleary ◽

Courtney V Fletcher ◽

Daniel P Healy ◽

Charles A Peloquin

Keyword(s):

Infectious Diseases ◽

English Language ◽

Data Extraction ◽

Information Service ◽

Ulcer Disease ◽

Additional Information ◽

Study Selection ◽

Enterococcus Spp ◽

Scientific Meetings ◽

Clinically Significant

Objective: To update readers on the significant changes in infectious diseases pharmacotherapy. Data Sources: An Index Medians and Iowa Drug Information Service search (1993–1994) of English-language literature pertaining to the selected topic areas was performed. Additional information from abstracts presented at scientific meetings were identified by the authors. Study Selection and Data Extraction: All identified studies were screened and those judged relevant to the update were evaluated. Data Synthesis: New or clinically significant data since 1992 that related to peptic ulcer disease, microbial resistance (e.g., Enterococcus spp., Streptococcus pneumoniae, Mycobacterium tuberculosis, Candida albicans), immunomodulators, and AIDS were evaluated and compared with previous data. Conclusions: There have been several exciting and significant changes in infectious diseases pharmacotherapy evident from this review.

Download Full-text

Parenteral Histamine2-Receptor Antagonists in the Pediatric Population

Journal of Pharmacy Technology ◽

10.1177/875512259401000203 ◽

1994 ◽

Vol 10 (2) ◽

pp. 53-57

Author(s):

Neeta Bahal O'Mara ◽

Milap C. Nahata

Keyword(s):

Product Information ◽

Pediatric Population ◽

Data Extraction ◽

Infants And Children ◽

Optimal Dosage ◽

Receptor Antagonists ◽

Study Selection ◽

Stability Data ◽

Administration Methods ◽

In Infants And Children

Objective: To provide a review of the use of parenteral histamine2 (H2)-receptor antagonists cimetidine, ranitidine, and famotidine in the pediatric population. Data Sources: Information was identified by MEDLINE and a review of journals. References cited in published articles and manufacturers' product information also were used. Study Selection: Information was selected for review if it addressed the parenteral administration of H2-receptor antagonists in the pediatric population. Data Extraction: Data were extracted from references pertaining to the topic. Data Synthesis: Despite the lack of Food and Drug Administration pediatric labeling, the H2-receptor antagonists often are used for a variety of indications in infants and children. Although these agents differ somewhat in chemical structure, potency, and pharmacokinetics, the most important differences exist in their drug interactions and adverse effect profiles. Further, administration methods, compatibility, and stability data differ slightly among the agents. Conclusions: Parenteral H2-receptor antagonists are used for a variety of indications in infants and children. Despite their widespread use, additional studies are needed to define the optimal dosage regimens in this population.

Download Full-text